Troy Lister

Chief Scientific Officer, Verve Therapeutics, Inc.

Companies

Verve Therapeutics, Inc.Chief Scientific Officer Jun 25, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Verve Therapeutics, Inc.0 shares²Jul 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 25, 2025U 6,952 shares of Verve Therapeutics, Inc.²
Apr 2, 2025Sold 2,189 shares at $4.15 of Verve Therapeutics, Inc.³
Apr 1, 2025Exercised options 7,340 shares of Verve Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVerve Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARVerve Therapeutics, Inc. shares after the filing of Jul 25, 2025
3
SEC EDGARForm 4 filed Apr 3, 2025